Alimera sciences announces participation at the 11th annual craig-hallum alpha select conference on tuesday, november 17, 2020

Atlanta, nov. 16, 2020 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that rick eiswirth, alimera's president and chief executive officer, will participate in the craig-hallum capital group's annual alpha select conference on tuesday november 17, 2020. the conference consists of one-on-one and small group meetings, which will take place via video conference.
ALIM Ratings Summary
ALIM Quant Ranking